AstraZeneca reaffirms COVID-19 vaccine Covishield safety amidst rare side effect concerns

After AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination initiated legal action against Serum Institute of India. Covishield, developed by AstraZeneca and Oxford University, faced scrutiny. Another family shared the plight of their daughter, who succumbed to post-vaccination complications. Safety concerns prompted regulatory scrutiny and legal action, despite the vaccine's proven efficacy against Covid-19. #covishield #covishieldsideeffects #covishieldnews #covishieldvaccine #covishieldsideeffectsnews #covishieldnewstoday #covishieldvaccinenews #Oneindia #Oneindianews ~PR.320~GR.123~ED.155~HT.318~